tradmap

TNON Earnings Tenon Medical, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$21868 -$10934 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $2M $4M 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$19M -$9M $0 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$763 -$336 $92 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $740500 $1M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$4M -$2M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–25 of 25
Q2 20262026-06-30-12.352026-08-1310-Q
Q1 20262026-03-3110.852026-05-1510-Q
Q4 2025 (derived)2025-12-31-68.092026-03-2710-K
FY 20252025-12-31-59.502026-03-2710-K
Q3 20252025-09-30-14.002025-11-1310-Q
Q2 20252025-06-30-12.762025-08-1310-Q
Q1 20252025-03-3135.352025-05-1310-Q
Q4 2024 (derived)2024-12-3191.812025-03-2610-K
FY 20242024-12-31-394.102025-03-2610-K
Q3 20242024-09-30-127.052024-11-1410-Q
Q2 20242024-06-30-8.162024-08-1310-Q
Q1 20242024-03-31-350.702024-05-1510-Q
Q4 2023 (derived)2023-12-31-763.012024-03-2910-K
FY 20232023-12-31-2402.402024-03-2910-K
Q3 20232023-09-30-409.152023-11-1410-Q
Q2 20232023-06-30-26.242023-08-1110-Q
Q1 20232023-03-31-1204.002023-05-0910-Q
Q4 2022 (derived)2022-12-31892.002023-03-1010-K
FY 20222022-12-31-6613.602023-03-1010-K
Q3 20222022-09-30-789.602022-11-1010-Q
Q2 20222022-06-30-52.002022-08-1210-Q
Q1 20222022-03-31-6664.00——
FY 20212021-12-31-21868.00——
Q3 20212021-09-30-7140.00——
Q2 20212021-06-30-160.80——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.